Not checked for notices yet.
Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells
Graham MacLeod, Danielle A. Bozek, Nishani Rajakulendran and 14 more
Cell Reports · 2019
doi:10.1016/j.celrep.2019.03.047
Cited by papers we hold 5
- Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress · 2021No notice
- PRMT5 inhibition disrupts splicing and stemness in glioblastoma · 2021No notice
- Tumour treating fields therapy for glioblastoma: current advances and future directions · 2020Corrected
- Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer · 2020No notice
- Identifying chemogenetic interactions from CRISPR screens with drugZ · 2019No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.